Urologic neoplasms
Clinical trials for Urologic neoplasms explained in plain language.
Never miss a new study
Get alerted when new Urologic neoplasms trials appear
Sign up with your email to follow new studies for Urologic neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A pill instead of surgery? trial tests vepugratinib against Low-Grade bladder cancer
Disease control Not yet recruitingResearchers are testing whether an oral drug called vepugratinib can clear low-grade, intermediate-risk bladder cancer that has not invaded muscle, or low-grade upper tract urothelial cancer. The trial enrolls adults whose tumors carry a specific change in the FGFR3 gene. Partici…
Matched conditions: UROLOGIC NEOPLASMS
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Two-Pronged immune attack shrink kidney tumors before surgery?
Disease control Not yet recruitingThis trial is testing whether giving a combination of an experimental immunotherapy (epalolitoworelimab) and a targeted therapy (lenvatinib) before and after surgery can improve outcomes for people with high-risk clear cell kidney cancer. The treatment is given first to shrink th…
Matched conditions: UROLOGIC NEOPLASMS
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC